opinions please

  1. 7,397 Posts.
    Any body follow this one I see it is trading near its NTA of 22c .
    Looks like it has a proper business model as well,
    Has a price target of 40c


    Date Mon, 13 May 2002

    The Australian-listed medical technology group, Axon Instruments, has downgraded its first-half profit forecast.
    The company is now expecting a loss of between $US3m and $US4m. The company's management attributed the forecast loss to the effect of "weak trading" in the global gene micro-array market.
    Following news of Axon's expected loss, the company's share value fell, reducing Axon's market capitalisation by almost a quarter.
    On 10 May 2002, the shares closed $A0.03 lower at $A0.33. Brokers such as Deutsche Bank have reduced their price targets for Axon from $A0.63 per share to $A0.40.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.